University of Oxford logo

University of Oxford

Europe, Oxfordshire, United Kingdom, Oxford

Description

Oxford is renowned for its academic excellence, historic colleges, and contributions to research and scholarship.

Investor Profile

University of Oxford has made 28 investments, with 7 in the past 12 months and 4% as lead.

Stage Focus

  • Series A (39%)
  • Series Unknown (21%)
  • Series B (18%)
  • Seed (18%)
  • Series D (4%)

Country Focus

  • United Kingdom (96%)
  • United States (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Information Technology
  • Software
  • Life Science
  • Chemical
  • Location Based Services
  • Mobile Apps
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does University of Oxford frequently co-invest with?

Oxford Investment Consultants LLP
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 5
G. K. Goh
Asia, Central Region, Singapore, Singapore
Co-Investments: 4
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 2
HealthQuest Capital
North America, California, United States, Redwood City
Co-Investments: 2
Big Pi Ventures
Europe, Attiki, Greece, Athens
Co-Investments: 3
Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 2
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 3
IP Group
Europe, England, United Kingdom, London
Co-Investments: 5
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 4
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 17

Which angels does University of Oxford often collaborate with?

GR
Europe, United Kingdom
Shared Deals: 1

What are some of recent deals done by University of Oxford?

Seloxium

Oxford, Oxfordshire, United Kingdom

Seloxium is innovative research that makes it possible to extract necessary metals in an environmentally friendly manner.

MiningRecyclingWater Purification
SeedMar 20, 2025
Amount Raised: $6,000,000
OrganOx

Oxford, Oxfordshire, United Kingdom

OrganOx is a medical technology company.

Health CareMedicalMedical Device
Series UnknownFeb 24, 2025
Amount Raised: $142,000,000
Diffblue

Oxford, Oxfordshire, United Kingdom

Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.

Artificial Intelligence (AI)Developer ToolsGenerative AISoftware
Series AOct 30, 2024
Amount Raised: $6,300,000
FluoRok

Oxford, Oxfordshire, United Kingdom

FluoRok is revolutionizing the way fluorochemicals are produced globally.

ChemicalManufacturing
SeedSep 23, 2024
Amount Raised: $10,279,688
Beacon Therapeutics

London, England, United Kingdom

Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.

Health CareTherapeutics
Series BJun 3, 2024
Amount Raised: $170,000,000
Oxford Endovascular

Oxford, Oxfordshire, United Kingdom

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

BiotechnologyHealth CareMedical
Series AMay 20, 2024
Amount Raised: $10,167,678
Theolytics

Oxford, Oxfordshire, United Kingdom

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

BiotechnologyMedicalTherapeutics
Series UnknownApr 17, 2024
Amount Raised: $23,660,858
NodeShift

San Francisco, California, United States

NodeShift is a cloud service provider that enables companies to create and run safe applications on a budget.

Cloud InfrastructureInformation TechnologyInternetWeb3
SeedFeb 21, 2024
Amount Raised: $3,200,000
Navenio

Oxford, Oxfordshire, United Kingdom

Navenio is a software company that provides location positioning services for indoor environments through its mobile app.

Information TechnologyLocation Based ServicesMobile AppsSoftware
Series ASep 20, 2023
Amount Raised: $6,300,000
Theolytics

Oxford, Oxfordshire, United Kingdom

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

BiotechnologyMedicalTherapeutics
Series AAug 25, 2023
Amount Raised: $27,797,378